CERC-Asia is the new Asian subsidiary of CERC, a reputable high-quality dedicated CRO in Europe founded by KOL in Interventional Cardiovascular medicine.

Since 2008 CERC-Europe has achieved an excellent track record in regulatory guidance, trial design, strategic planning, global study management and monitoring, and provides support for communication and publications in major congresses and journals.

Over the past few years CERC-Europe has already successfully conducted clinical trials in Asia. Driven by CERC’s wide experience in cardiovascular research CERCAsia has been conceived with the purpose of underpinning the development of cardiovascular clinical research in Asia.

CERC-Asia’s objectives are to provide better guidance and logistical support in conducting clinical trials, act as a local dedicated CRO and support industry trials.

CERC also provides assistance to investigator-sponsored trials (investigator-initiated-trials) via a dedicated non-profit structure called CERIC.

The Company is ISO 9001 certified and was successfully audited by all major players in the interventional field.

541 Orchard Road #09-01 Liat Towers

godaddy vs fatcow